Amazon’s Bio Discovery tool pushes AI deeper into drug design with lab testing already under way

AWS has launched Amazon Bio Discovery, an AI application aimed at speeding early-stage drug research. Amazon says Memorial Sloan Kettering used the system to compress an antibody design process from a year into weeks, an early signal that AI drug discovery is moving from pitch decks to workflow.

By |2026-04-23T03:48:47+00:00April 23, 2026|News|Comments Off on Amazon’s Bio Discovery tool pushes AI deeper into drug design with lab testing already under way

Anthropic’s $100 Billion Amazon compute deal puts AI infrastructure at the center of the race

Anthropic has agreed to spend $100 billion for up to 5 gigawatts of compute from Amazon, a deal that highlights how the AI race is shifting toward industrial-scale infrastructure and long-term capacity planning.

By |2026-04-23T03:20:29+00:00April 23, 2026|News|Comments Off on Anthropic’s $100 Billion Amazon compute deal puts AI infrastructure at the center of the race

Amazon boosts Anthropic stake to $5 billion as AI compute race intensifies

Amazon is investing another $5 billion in Anthropic and may add $20 billion more, a deal that turns one of AI’s most important rivalries into a long-horizon bet on compute, cloud capacity and model scale.

By |2026-04-21T03:18:22+00:00April 21, 2026|News|Comments Off on Amazon boosts Anthropic stake to $5 billion as AI compute race intensifies

OpenAI Secures $110 Billion in New Funding as Amazon Leads Massive AI Bet

OpenAI said on April 10, 2026, that it has secured $110 billion in funding from Amazon, Nvidia and SoftBank, a deal that values the company at $730 billion before the new money. The company said the capital will help

By |2026-04-13T00:35:40+00:00April 10, 2026|News|Comments Off on OpenAI Secures $110 Billion in New Funding as Amazon Leads Massive AI Bet
Go to Top